Regarding the articles addressing the immune response in RHD patients, 68.18% (n = 15) assessed cytokine and chemokine profiles, while studies focusing on CD4+ and CD8+ T cell responses, with or without association with soluble factors, accounted for 31.82% (n = 7). The gene discussed is CD8A; the disease is rheumatic heart disease.